Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study
This observational study suggests that selexipag may be strongly effective in treating DUs refractory to conventional drugs.
Authors
- Laura Giudice (ORCID: https://orcid.org/0000-0001-7880-1797)
- Giuseppe Armentaro (ORCID: https://orcid.org/0000-0001-9775-9715)
- Marco Di Battista (ORCID: https://orcid.org/0000-0002-4788-5729)
- Marta Mosca (ORCID: https://orcid.org/0000-0001-5937-4574)
- Fabio Cacciapaglia (ORCID: https://orcid.org/0000-0001-7479-4462)
- Silvia Cavalli
- Martina Orlandi (ORCID: https://orcid.org/0000-0001-6784-2235)
- Dilia Giuggioli (ORCID: https://orcid.org/0000-0002-0041-3695)
- Stefano Stano (ORCID: https://orcid.org/0000-0001-5207-7913)
- Maria Rosa Pellico (ORCID: https://orcid.org/0009-0004-1921-7370)
- Claudia Iannone (ORCID: https://orcid.org/0009-0005-5686-0127)
- Nicoletta Del Papa (ORCID: https://orcid.org/0000-0003-1549-8852)
- I. Magi
- Alessandra Della Rossa (ORCID: https://orcid.org/0000-0002-3165-1565)
- Antonina Minniti (ORCID: https://orcid.org/0000-0002-1152-0322)
- C. Bochicchio
- Antonio Tavoni
- Roberto Caporali
- M. Sette
Institutions
- University of Pisa (IT)
- University of Modena and Reggio Emilia (IT)
- University of Milan (IT)
- Istituto Ortopedico Gaetano Pini (IT)
- Ospedale Generale Regionale Francesco Miulli (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1093/rheumatology/keaf292
- Citations
- 2
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.94